RxDoctor Payments Data

Nidal Elbaridi, MD

Pain Medicine · Chicago, ILNPI 1780821264

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,539 and has fallen 76.3% since, to $365 in 2025.

$5,503in general payments, 2019–2025

Across 178 payments — averaging $30.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$912
  • Boston Scientific$881
  • Medtronic$816
  • Nalu Medical, Inc.$604
  • Merz North America, Inc.$567
  • Nevro Corp.$381
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$5,503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,503 in reported general payments places this provider in the 70th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois →

Medicare billing

Part B allowed, 2024
$251,266
Medicare patients
119
Services billed
1,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$10,747
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen266$6,796
Celecoxib91$3,690
Fentanyl33$3,492
Gabapentin112$1,295
Tramadol Hcl129$788
Cyclobenzaprine Hcl38$659
Pregabalin29$504
Morphine Sulfate ErMorphine Sulfate33$437
Oxycodone Hcl21$403
Carisoprodol12$203
Duloxetine Hcl15$161
Naproxen12$126
Baclofen21$126
Acetaminophen-CodeineAcetaminophen With Codeine14$107

Paid to pharmacies, not to this prescriber.

Other pain medicine in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →